Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY TrialD. Ross Camidge, Shun Lü, İrfan Çiçin et al.|Journal of Clinical Oncology|2024Cited by 131
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung AdenocarcinomaHourin Cho, Hidehito Horinouchi, Kouya Shiraishi et al.|Journal of Thoracic Oncology|2025Cited by 6
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analysesKouya Shiraishi, Kazuki Kumada, Atsushi Takahashi et al.|Cancer Communications|2023Cited by 4